Brown, Lisle/Cummings, Inc. Embecta Corp. Transaction History
Brown, Lisle/Cummings, Inc.
- $335 Billion
- Q4 2024
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Embecta Corp. stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 178 shares of EMBC stock, worth $2,643. This represents 0.0% of its overall portfolio holdings.
Number of Shares
178
Previous 178
-0.0%
Holding current value
$2,643
Previous $2.51 Million
46.45%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding EMBC
# of Institutions
405Shares Held
53.6MCall Options Held
172KPut Options Held
22.4K-
Black Rock Inc. New York, NY9.19MShares$137 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.03MShares$104 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.27MShares$48.6 Million1.68% of portfolio
-
American Century Companies Inc Kansas City, MO3.26MShares$48.4 Million0.04% of portfolio
-
River Road Asset Management, LLC3.25MShares$48.2 Million0.95% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $859M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...